Chief Financial Officer

Med Pal AI plc is the AI-native digital health and pharmacy group listed on the London Stock Exchange (AIM: MPAL). The Group combines NHS Distance Selling Pharmacy hubs at Sarus Court (Runcorn) and Swaffham, a B2B care home pharmacy supply business, New Health (), the Group's dedicated private GLP-1 weight-management clinic, and the Med Pal Health OS app with Juno, our agentic AI health companion.

Med Pal is the only London-listed plc focused on GLP-1 and the only GLP-1 service with a fully integrated health and wellness app. Our ambition is to become a top-three UK GLP-1 player, supported by partnerships with Novo Nordisk, Eli Lilly, Epassi and Care UK, and by a pipeline of acquisitions in UK pharmacy and health technology.

The Group is growing quickly, is acquisitive, and is an active user of the public markets. The CFO sits at the centre of all of that.

Following the resignation of our current CFO, we are appointing a Chief Financial Officer to lead the finance function through Med Pal's next phase of growth. This is a hands-on, board-level role in a lean organisation. We are looking for one person who is, at the same time, three things:

• An outstanding plc CFO: credible with the Board, the NOMAD, brokers, auditors and the market; someone who has owned financial strategy, fundraising, governance and reporting in a UK listed company of comparable scale.
• A first-class accountant: technically strong, close to the numbers, and personally involved in month-end, cash, controls, audit and statutory reporting. This is not a role that can be delegated downwards.
• A compelling presenter of the company and its forecasts to investors: able to build the investment case, own the model behind it, and present it with confidence and precision to institutional investors, private client brokers, analysts and lenders, in London and on the road.

The CEO's expectation is explicit: we want a CFO who does the work, not one who only builds and manages a team. The successful candidate will spend time in the detail of management accounts, cashflow, pharmacy margins and the forecast model, and will be equally comfortable presenting those numbers to the market the following week.

• Act as the Group's lead financial voice to the market alongside the CEO: institutional and retail investors, private client brokers, analysts, lenders and the financial press.
• Prepare and present interim and full-year results, results presentations, investor decks and roadshow materials; lead investor and broker meetings in London and elsewhere, including extended stays around results and fundraisings.
• Own the investment case and the forecast model that underpins it; be able to defend every assumption in front of an investor.
• Lead equity and debt fundraising from planning through to completion, including placings, subscriptions, warrant and option exercises, debt facilities and any other capital raising the Board approves.
• Manage the day-to-day relationship with the NOMAD, corporate brokers, registrars, financial PR and IR advisers; ensure the Group is always ready to raise capital when the opportunity arises.
• Maintain the share, warrant and option registers and the fully diluted capital table, and ensure they reconcile to all announcements and contractual commitments.

• Personally review, and where necessary prepare, the monthly management accounts, balance sheet reconciliations and KPI packs for each business unit (NHS pharmacy hubs, care home supply, New Health GLP-1 clinic, technology).
• Own the month-end close: timetable, accruals, prepayments, stock, intercompany, revenue recognition and margin analysis.
• Prepare and deliver…